[{"address1": "200 Pine Street", "address2": "Suite 400", "city": "San Francisco", "state": "CA", "zip": "94104", "country": "United States", "phone": "415 371 8300", "website": "https://jaguar.health", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. The company operates through two segments, Animal Health and Human Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. The company offers Mytesi, an anti-secretory antidiarrheal drug for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy; and Canalevia-CA1, a prescription drug product for chemotherapy-induced diarrhea in dogs. It is also developing Crofelemer, an anti-secretory antidiarrheal drug, which is in Phase III clinical trial for prophylaxis of diarrhea in adult cancer patients; Phase II clinical trials for rare/orphan disease indications, including short bowel syndrome with intestinal failure and microvillus inclusion disease; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, the company is developing Mytesi which is in Phase III clinical trial for cancer therapy-related diarrhea, as well as Phase II clinical trial for irritable bowel syndrome; and NP-300, a second-generation antidiarrheal drug that is in Phase I clinical trial for symptomatic relief and treatment of moderate-to-severe diarrhea. The company is headquartered in San Francisco, California.", "fullTimeEmployees": 49, "companyOfficers": [{"maxAge": 1, "name": "Ms. Lisa A. Conte", "age": 65, "title": "Founder, CEO, President & Director", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 693865, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pravin R. Chaturvedi Ph.D.", "age": 61, "title": "Chief Scientific Officer & Chair of Scientific Advisory Board", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 592507, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven R. King Ph.D.", "age": 66, "title": "Chief of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Secretary", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 461782, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Hodge", "title": "Senior Director of Investor Relations, Business Development & Special Events", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karen J. Brunke Ph.D.", "age": 71, "title": "Executive VP of Corporate & Business Development", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Sesin Ph.D.", "title": "Chief Manufacturing Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Massimo  Radaelli M.B.A., Ph.D.", "age": 66, "title": "President of Jaguar International", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Catherine Miller Collis", "title": "Senior Vice President of Growth Strategy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Darlene P. Horton M.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.31, "open": 2.3, "dayLow": 2.19, "dayHigh": 2.3, "regularMarketPreviousClose": 2.31, "regularMarketOpen": 2.3, "regularMarketDayLow": 2.19, "regularMarketDayHigh": 2.3, "payoutRatio": 0.0, "beta": 0.58, "forwardPE": -0.85823756, "volume": 86830, "regularMarketVolume": 86830, "averageVolume": 107840, "averageVolume10days": 121830, "averageDailyVolume10Day": 121830, "bid": 2.18, "ask": 2.3, "bidSize": 1, "askSize": 1, "marketCap": 3653417, "fiftyTwoWeekLow": 2.19, "fiftyTwoWeekHigh": 35.25, "priceToSalesTrailing12Months": 0.3162584, "fiftyDayAverage": 3.4473, "twoHundredDayAverage": 15.26508, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 36460100, "profitMargins": 0.0, "floatShares": 915230, "sharesOutstanding": 1630990, "sharesShort": 39637, "sharesShortPriorMonth": 34177, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0299, "heldPercentInsiders": 0.09566, "heldPercentInstitutions": 0.053439997, "shortRatio": 0.4, "shortPercentOfFloat": 0.0306, "impliedSharesOutstanding": 1324470, "bookValue": 2.644, "priceToBook": 0.84720117, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -39730000, "trailingEps": -60.27, "forwardEps": -2.61, "lastSplitFactor": "1:25", "lastSplitDate": 1742774400, "enterpriseToRevenue": 3.156, "enterpriseToEbitda": -1.209, "52WeekChange": -0.92832, "SandP52WeekChange": 0.16932249, "quoteType": "EQUITY", "currentPrice": 2.24, "targetHighPrice": 40.0, "targetLowPrice": 16.0, "targetMeanPrice": 28.0, "targetMedianPrice": 28.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 5690000, "totalCashPerShare": 5.587, "ebitda": -30159000, "totalDebt": 38336000, "quickRatio": 0.251, "currentRatio": 1.079, "totalRevenue": 11552000, "debtToEquity": 1156.44, "revenuePerShare": 27.199, "returnOnAssets": -0.37479, "returnOnEquity": -4.59519, "grossProfits": 9512000, "freeCashflow": -16948124, "operatingCashflow": -29653000, "revenueGrowth": -0.058, "grossMargins": 0.82341003, "ebitdaMargins": -2.61072, "operatingMargins": -4.25519, "financialCurrency": "USD", "symbol": "JAGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1753486624, "regularMarketTime": 1753473600, "exchange": "NCM", "messageBoardId": "finmb_12827020", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "Jaguar Health, Inc.", "longName": "Jaguar Health, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1431437400000, "postMarketChangePercent": 0.892856, "postMarketPrice": 2.26, "postMarketChange": 0.02, "regularMarketChange": -0.0699999, "regularMarketDayRange": "2.19 - 2.3", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 107840, "fiftyTwoWeekLowChange": 0.049999952, "fiftyTwoWeekLowChangePercent": 0.022831028, "fiftyTwoWeekRange": "2.19 - 35.25", "fiftyTwoWeekHighChange": -33.01, "fiftyTwoWeekHighChangePercent": -0.9364539, "fiftyTwoWeekChangePercent": -92.832, "dividendDate": 1559865600, "earningsTimestamp": 1747339200, "earningsTimestampStart": 1755115200, "earningsTimestampEnd": 1755115200, "earningsCallTimestampStart": 1747340100, "earningsCallTimestampEnd": 1747340100, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -60.27, "epsForward": -2.61, "epsCurrentYear": -23.81, "priceEpsCurrentYear": -0.09407812, "fiftyDayAverageChange": -1.2073, "fiftyDayAverageChangePercent": -0.3502161, "twoHundredDayAverageChange": -13.025081, "twoHundredDayAverageChangePercent": -0.85325986, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -3.0303, "regularMarketPrice": 2.24, "displayName": "Jaguar Health", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]